The first vaccine to protect African children against malaria could be available in 2017 in the best case scenario. PHOTO | FILE
The first vaccine to protect African children against malaria could be available in 2017 in the best case scenario.
Although the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine Mosquirix for use in African children aged six weeks to 17 months, its analysis of the vaccine results show that it is not as effective against the disease as was hoped.
